NATIONAL NEWS

US Allows Emergency COVID-19 Vaccine In Bid To End Pandemic

Dec 11, 2020, 7:33 PM | Updated: 8:21 pm
A phial of the Pfizer/BioNTech COVID-19 vaccine ready for administration at Guy's Hospital at the s...
A phial of the Pfizer/BioNTech COVID-19 vaccine ready for administration at Guy's Hospital at the start of the largest ever immunisation programme in the UK's history on December 8, 2020 in London, United Kingdom. More than 50 hospitals across England were designated as covid-19 vaccine hubs, the first stage of what will be a lengthy vaccination campaign. NHS staff, over-80s, and care home residents will be among the first to receive the Pfizer/BioNTech vaccine, which recently received emergency approval from the country's health authorities. (Photo by Victoria Jones - Pool / Getty Images)
(Photo by Victoria Jones - Pool / Getty Images)

WASHINGTON (AP) — The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.

Shots for health workers and nursing home residents are expected to begin in the coming days after the Food and Drug Administration authorized an emergency rollout of what promises to be a strongly protective vaccine from Pfizer Inc. and its German partner BioNTech.

Initial doses are scarce and rationed as the U.S. joins Britain and several other countries in scrambling to vaccinate as many people as possible ahead of a long, grim winter. It will take months of work to tamp down the coronavirus that has surged to catastrophic levels in recent weeks and already claimed 1.5 million lives globally.

While the FDA decision came only after public review of data from a huge ongoing study, it has also been dogged by intense political pressure from the Trump administration, which has accused the agency of being too slow and even threatened to remove FDA chief Stephen Hahn if a ruling did not come Friday.

The move sets off what will be the largest vaccination campaign in U.S. history — but it also has global ramifications because it’s a role model to many other countries facing the same decision.

It offers the ability “in this situation where the pandemic is out of control, to bring hope to the people,” Dr. Ugur Sahin, CEO of BioNTech, told The Associated Press.

The world desperately needs multiple vaccines for enough to go around, and the Pfizer-BioNTech shot is the first based on rigorous scientific testing to emerge from that worldwide race — a record-setting scientific achievement that shaved years off the usual process.

“I don’t think you would have found a scientist on this planet that would have predicted this 11 months ago,” said Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia who advises the FDA.

The U.S. is considering a second vaccine, made by Moderna Inc., that could roll out in another week. In early January, Johnson & Johnson expects to learn if its vaccine is working in final testing.

Europe is set to make its own decision on the Pfizer-BioNTech and Moderna shots later this month, an important step as some other candidates that multiple countries were anxiously awaiting have hit roadblocks. Friday, Sanofi and GSK announced a months-long delay after early tests showed their vaccine didn’t work well enough in older adults.

And China and Russia didn’t wait for final-stage tests before beginning vaccinations with some homegrown shots.

President Donald Trump said late Friday that Pfizer had “passed the gold standard of safety,” in a video statement hailing the vaccine as “one of the greatest scientific accomplishments in history.”

About 3 million doses of the Pfizer-BioNTech vaccine are expected in the first shipments around the country, according to officials with Operation Warp Speed, the Trump administration’s vaccine development program. A similar amount is to be held in reserve for those recipients’ second dose.

The government still is hammering out final recommendations, but expected to follow health workers and nursing homes are other essential workers, older adults and people at high risk because of other health problems. U.S. authorities don’t expect enough for the general population before spring, and that’s assuming there are no manufacturing glitches.

“We would need at least until March, April, to have an impact on the pandemic,” BioNTech’s Sahin said. But he predicted that protecting the most vulnerable could start putting a dent in hospitals and deaths sooner.

In a still unfinished study of nearly 44,000 people, the FDA found the vaccine was safe and more than 90% effective across recipients of different ages, including older adults, races and those with health problems that put them at high risk from the coronavirus. It’s authorized for people age 16 and up.

Emergency use means the vaccine still is experimental. Most important for would-be recipients to know:

–Some protection begins after the first dose, but it takes a second dose three weeks later for full protection. It’s unclear how long protection lasts.

—The vaccine protects against COVID-19 illness, but no one yet knows if it can stop the silent, symptomless spread that accounts for roughly half of all cases. The ongoing study will attempt to answer that but for now, the vaccinated still will need to wear a mask and keep their distance.

—Expect a sore arm and some flu-like symptoms such as fever, fatigue, headache and chills after the second dose. While uncomfortable, those reactions only last about a day. “That’s just your immune system working. It’s a good thing,” Offit said.

—Authorities are investigating several allergic reactions reported in Britain by health workers with a history of severe allergies. The FDA said people must have treatments for allergic reactions on hand before they are administered the COVID-19 vaccine, and not give it to those with a known history of severe allergic reactions to any of its ingredients.

—Every vaccine recipient must be given an FDA-written fact sheet about the vaccine and its known risks and benefits.

—FDA didn’t forbid the vaccine’s use in pregnant women but noted there isn’t enough evidence to determine its safety in that group.

If emergency use of Moderna’s vaccine also is authorized, the U.S. expects to vaccinate 20 million people by the end of December. They hope to have enough for another 30 million people in January and 50 million in February.

Globally, Sahin said production should scale up considerably in February, with Pfizer and BioNTech projecting 120 million to 130 million doses a month to reach 1.3 billion doses in 2021.

Getting shots into arms is the big challenge, especially as a new poll from The Associated Press-NORC Center for Public Affairs Research found only half of Americans want the vaccine when it’s their turn. About a quarter say they won’t get it and the rest aren’t sure.

Political interference has complicated health authorities’ message that the testing was rigorous and cut no corners.

Trump bashed the FDA, again, Friday for taking too long, complaining that the agency “is still a big, old slow turtle.” One of his deputies even pressed Hahn to clear the shots by the end of the day or face possible firing, two administration officials said.

The FDA is unique in analyzing drugmakers’ raw data, a process that takes longer than many other countries’ regulatory reviews. In addition, the FDA insisted that large COVID-19 vaccine studies track at least half the participants for two months to look for side effects, a time period when historically any vaccine problems appear.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

KSL 5 TV Live

Top Stories

National News

WASHINGTON, DC - FEBRUARY 08:  U.S. Rep. Marjorie Taylor-Greene (R-GA) holds up a poster of a Twitt...
Farnoush Amiri and Barbara Ortutay

Ex-Twitter execs deny pressure to block Hunter Biden story

Former Twitter executives conceded to Congress that they made a mistake by blocking a story about Hunter Biden, the president’s son, from the social media platform in the run-up to the 2020 election.
1 day ago
A general view of atmosphere the premiere of Walt Disney Animation Studios' "Frozen"at the El Capit...
Alli Rosenbloom

Disney announces more ‘Toy Story’ and ‘Frozen’ sequels are in the works

Disney CEO Bob Iger said on Wednesday during the company's earnings call that there are plans for additional sequels to both hit franchises in the works.
1 day ago
Patrick Crusius...
Ashley Killough and Holly Yan, CNN

Suspect in El Paso Walmart massacre pleads guilty to 90 federal charges

Patrick Crusius plead guilty to all federal charges on Wednesday, nearly three and a half years after the 2019 mass shooting at a Walmart in El Paso, Texas -- one of the deadliest attacks on Latinos in modern US history.
1 day ago
The Twitter emblem is displayed on a smart phone outside the Twitter offices in Dublin on November ...
CNN

Twitter users briefly unable to tweet, send messages

Twitter users on Wednesday briefly encountered various issues with the platform, including the inability to tweet, send direct messages or follow new accounts.
1 day ago
President Joe Biden delivers the State of the Union address to a joint session of Congress at the C...
Zeke Miller, Seung Min Kim and Lisa Mascaro, Associated Press

Biden in State of Union exhorts Congress: ‘Finish the job’

President Joe Biden has exhorted Republicans in his State of the Union address to work with him to “finish the job” of rebuilding the economy and uniting the nation.
1 day ago
Rep. George Santos, R-N.Y., Rep. Matt Gaetz, R-Fla., and other Republicans gather in the House Cham...
Lisa Mascaro and Mary Clare Jalonick, Associated Press

GOP on GOP: Romney scolds Santos, ‘You don’t belong here’

Congressman George Santos' presence at the center aisle for Tuesday night's speech was met with a stern rebuke from a fellow Republican, Sen. Mitt Romney of Utah.
1 day ago

Sponsored Articles

vintage photo of lighting showroom featuring chandeliers, lamps, wall lights and mirrors...
Lighting Design

History of Lighting Design | Over 25 Years of Providing Utah With the Latest Trends and Styles

Read about the history of Lighting Design, a family-owned and operated business that paved the way for the lighting industry in Utah.
Fiber Optical cables connected to an optic ports and Network cables connected to ethernet ports...
Brian Huston, CE and Anthony Perkins, BICSI

Why Every Business Needs a Structured Cabling System

A structured cabling system benefits businesses by giving you faster processing speeds and making your network more efficient and reliable.
notebook with password notes highlighted...
PC Laptops

How to Create Strong Passwords You Can Actually Remember

Learn how you can create strong passwords that are actually easy to remember! In a short time you can create new ones in seconds.
house with for rent sign posted...
Chase Harrington, president and COO of Entrata

Top 5 Reasons You May Want to Consider Apartment Life Over Owning a Home

There are many benefits of renting that can be overshadowed by the allure of buying a home. Here are five reasons why renting might be right for you.
Festive kitchen in Christmas decorations. Christmas dining room....
Lighting Design

6 Holiday Decor Trends to Try in 2022

We've rounded out the top 6 holiday decor trends for 2022 so you can be ahead of the game before you start shopping. 
Happy diverse college or university students are having fun on their graduation day...
BYU MBA at the Marriott School of Business

How to Choose What MBA Program is Right for You: Take this Quiz Before You Apply!

Wondering what MBA program is right for you? Take this quiz before you apply to see if it will help you meet your goals.
US Allows Emergency COVID-19 Vaccine In Bid To End Pandemic